Filter
1105
Filtered Results: 1105
Text search:
World
Health
Organization,
Eastern
Mediterranean
Featured
Recommendations
148
New Publications
193
Language
Document type
No document type
352
Studies & Reports
304
Guidelines
185
Manuals
85
Strategic & Response Plan
66
Fact sheets
35
Situation Updates
23
Training Material
22
Resource Platforms
17
Infographics
12
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
117
Syria
37
Africa
30
Middle East and North Africa
25
Western and Central Europe
22
Somalia
14
Yemen
13
Sudan
11
Latin America and the Carribbean
10
South–East Asia Region
9
Ethiopia
9
Pakistan
9
Nigeria
8
Afghanistan
8
West and Central Africa
8
Eastern Europe
8
Kenya
7
Congo, Democratic Republic of
7
East and Southern Africa
6
Lebanon
6
South Africa
6
Liberia
6
Sierra Leone
5
Iran
5
Asia
5
Jordan
5
Eastern Europe and Central Asia
5
India
5
Myanmar / Burma
5
Nepal
4
Turkey
4
Rwanda
4
Senegal
4
Saudi Arabia
4
Uganda
4
Iraq
4
Ukraine
3
Ghana
3
China
3
Venezuela
3
Russia
3
Egypt
3
Greece
3
Libya
3
South Sudan
3
North Macedonia
2
Thailand
2
Benin
2
Albania
2
USA
2
Cambodia
2
Western Pacific Region
2
Bangladesh
2
Brazil
2
Djibouti
2
Ecuador
2
Madagascar
2
Colombia
1
Mexico
1
Serbia
1
Cameroon
1
Niger
1
Burkina Faso
1
Malawi
1
Morocco
1
Qatar
1
Philippines
1
Guinea
1
Italy
1
Croatia
1
Tanzania
1
Paraguay
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Sri Lanka
1
Palestine
1
Georgia
1
Central African Republic
1
Mali
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
155
Clinical Guidelines
142
Public Health
119
Women & Child Health
90
Key Resources
77
Capacity Building
31
Pharmacy & Technologies
21
Toolboxes
Mental Health
133
COVID-19
113
Planetary Health
68
HIV
57
TB
56
NTDs
56
NCDs
45
Refugee
44
Conflict
42
Global Health Education
42
Caregiver
40
AMR
39
Rapid Response
33
Disability
31
Malaria
28
2.0 Rapid Response
28
Pharmacy
24
Ebola & Marburg
20
Polio
18
Cholera
16
Natural Hazards
14
Health Financing Toolbox
11
Zika
10
Specific Hazards
4
Social Ethics
1
Typhoon
1
The Priority medicines for mothers and children 2011 list was updated following the 18th Expert Committee Meeting
on Selection and Use of Medicines, the release of new treatment guidelines and feedback from partners following
the 2011 version. In alignment with the UN Global strategy f...
Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preve...
This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating procedures described in the WHO handbook for guideline d...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Technical Report
AIDS Medicines and diagnostics service
September 2016
The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable ...
Version 4
The purpose of these standard operating procedures (SOPs) is to offer policy guidance and to provide performance standards on how to respond to any type of poliovirus outbreak or event in a timely and effective manner, and specifically, to stop an outbrea...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
